Karnataka challenges safe harbour protection in case against Snapdeal over sale of erectile dysfunction pills
The Karnataka government has moved the Supreme Court, challenging the quashing of criminal proceedings against Snapdeal and its co-founders, Kunal Bahl and Rohit Kumar Bansal, over the alleged sale of erectile dysfunction pills on its platform without a valid licence or a…
Intelligence analysis by Llama
The Karnataka government alleges that a third-party seller sold Suhagra-100 tablets through Snapdeal’s online marketplace, despite not having a valid licence, and supplied the drug without requiring a doctor’s prescription. The government argues that safe harbour protection should not override public health laws and that Snapdeal allegedly failed to exercise due diligence.
The Karnataka government is challenging a court decision that let Snapdeal off the hook for selling erectile dysfunction pills without a prescription. The government says Snapdeal should be held responsible for allowing the sale of these pills, even though it's just a third-party seller who did it. This case is important because it raises questions about whether online companies can be held responsible for what their users do.
Analysis
A $60B Vote of Confidence
The Karnataka government's move to challenge the quashing of criminal proceedings against Snapdeal and its co-founders is a significant development in the ongoing debate over safe harbour protection for online intermediaries. The case highlights the tension between the IT Act's safe harbour provisions and sectoral regulations that impose strict liability on all parties involved in the online sale of goods and services.
The Karnataka government alleges that a third-party seller sold Suhagra-100 tablets through Snapdeal’s online marketplace, despite not having a valid licence, and supplied the drug without requiring a doctor’s prescription. The government argues that safe harbour protection should not override public health laws and that Snapdeal allegedly failed to exercise due diligence.
This case is not an isolated incident. The lack of clear regulations and guidelines for online pharmacies has created a grey area that allows unlicensed pharmacies to operate on e-commerce platforms. The IT Act, which governs e-pharmacies and e-pharmacy portals, shields intermediaries from any liability for the violations committed by the ‘seller’ or the ‘buyer’. However, it does not deal with illegal websites selling drugs online nor does it provide a mechanism to deal with such sites.
The Snapdeal case raises a fundamental question: Is safe harbour absolute and does the IT Act prevail over sectoral regulations that impose strict liability on all parties involved in the online sale of goods and services? The answer to this question has significant implications for the online ecosystem in India.
Why Cursor?
The Karnataka government's decision to challenge the quashing of criminal proceedings against Snapdeal and its co-founders is a significant development in the ongoing debate over safe harbour protection for online intermediaries. The case highlights the tension between the IT Act's safe harbour provisions and sectoral regulations that impose strict liability on all parties involved in the online sale of goods and services.
The Karnataka government alleges that a third-party seller sold Suhagra-100 tablets through Snapdeal’s online marketplace, despite not having a valid licence, and supplied the drug without requiring a doctor’s prescription. The government argues that safe harbour protection should not override public health laws and that Snapdeal allegedly failed to exercise due diligence.
This case is not an isolated incident. The lack of clear regulations and guidelines for online pharmacies has created a grey area that allows unlicensed pharmacies to operate on e-commerce platforms. The IT Act, which governs e-pharmacies and e-pharmacy portals, shields intermediaries from any liability for the violations committed by the ‘seller’ or the ‘buyer’. However, it does not deal with illegal websites selling drugs online nor does it provide a mechanism to deal with such sites.
The Road Ahead
The Snapdeal case raises a fundamental question: Is safe harbour absolute and does the IT Act prevail over sectoral regulations that impose strict liability on all parties involved in the online sale of goods and services? The answer to this question has significant implications for the online ecosystem in India.
The Karnataka government's decision to challenge the quashing of criminal proceedings against Snapdeal and its co-founders is a significant development in the ongoing debate over safe harbour protection for online intermediaries. The case highlights the tension between the IT Act's safe harbour provisions and sectoral regulations that impose strict liability on all parties involved in the online sale of goods and services.
The Karnataka government alleges that a third-party seller sold Suhagra-100 tablets through Snapdeal’s online marketplace, despite not having a valid licence, and supplied the drug without requiring a doctor’s prescription. The government argues that safe harbour protection should not override public health laws and that Snapdeal allegedly failed to exercise due diligence.
Key points
- The Karnataka government has moved the Supreme Court, challenging the quashing of criminal proceedings against Snapdeal and its co-founders, Kunal Bahl and Rohit Kumar Bansal, over the alleged sale of erectile dysfunction pills on its platform without a valid licence or a pres…
- The government alleges that a third-party seller sold Suhagra-100 tablets through Snapdeal’s online marketplace, despite not having a valid licence, and supplied the drug without requiring a doctor’s prescription.
- The government argues that safe harbour protection should not override public health laws and that Snapdeal allegedly failed to exercise due diligence.
If the Supreme Court rules in favour of the Karnataka government, it could lead to stricter regulations for online pharmacies and e-commerce platforms. This could make it harder for unlicensed pharmacies to operate on these platforms, which would be a positive development for public health.
On the other hand, if the Supreme Court rules in favour of Snapdeal, it could set a precedent that allows online intermediaries to avoid liability for the actions of their users. This could lead to a proliferation of unlicensed pharmacies on e-commerce platforms, which would be a negative development for public health.
